Stock-Based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Shares Available for Grant
Beginning number of shares, available for grant (in shares)	5,438,296	5,231,624	1,819,223
2018 plan annual increase (in shares)	3,689,000	3,689,000	3,689,000
Ending number of shares, available for grant (in shares)	12,003,394	5,438,296	5,231,624	1,819,223
Shares Subject to Options Outstanding
Beginning number of shares, outstanding (in shares)	3,402,574	2,624,974	3,101,181
Granted (in shares)	1,000,760	1,051,466	345,774
Granted in connection with the Joint Venture Acquisition (in shares)		15,128
Exercised (in shares)	(51,124)	(228,311)	(693,074)
Canceled (in shares)	(339,307)	(60,683)	(128,907)
Ending number of shares, outstanding (in shares)	4,012,903	3,402,574	2,624,974	3,101,181
Options vested and exercisable, number of options (in shares)	2,401,061
Weighted-Average Exercise Price
Beginning balance of options outstanding (in usd per share)	$ 34.34	$ 29.17	$ 15.80
Granted (in usd per share)	30.80	44.86	119.82
Granted in connection with the Joint Venture Acquisition (in usd per share)		4.90
Exercised (in usd per share)	7.93	6.29	11.19
Canceled (in usd per share)	58.45	90.84	47.51
Ending balance of options outstanding (in usd per share)	31.76	$ 34.34	$ 29.17	$ 15.80
Options vested and exercisable, weighted average exercise price per share (in usd per share)	$ 25.39
Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value
Options outstanding, weighted average remaining contractual term (in years)	6 years 7 months 6 days	6 years 9 months 18 days	6 years 6 months	6 years 10 months 24 days
Options outstanding, aggregate intrinsic value	$ 39,115	$ 39,749	$ 193,014	$ 350,670
Options vested and exercisable, weighted average remaining contractual term (in years)	4 years 10 months 24 days
Options vested and exercisable, aggregate intrinsic value	$ 37,730
Equity Option
Shares Available for Grant
Granted (in shares)	(1,000,760)	(1,051,466)	(345,774)
Granted in connection with the Joint Venture Acquisition (in shares)		(15,128)
Canceled (in shares)	338,570	56,391	65,523
Restricted Stock Units
Shares Available for Grant
Granted (in shares)	(2,436,947)	(2,995,533)	(873,916)
Canceled (in shares)	1,049,447	490,525	315,988
Market-based restricted stock units canceled
Shares Available for Grant
Canceled (in shares)			558,254
PSUs
Shares Available for Grant
Granted (in shares)	(126,041)	(26,935)	(52,917)
Canceled (in shares)	51,829	59,818	56,243
Shares authorized under the 2023 Plan
Shares Available for Grant
Shares authorized under the 2023 Plan (in shares)	5,000,000